![Amy VandenBerg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy VandenBerg
No open positions remaining
Profile
Amy VandenBerg worked as a Vice President of Regulatory and Clinical Affairs at Obalon Therapeutics, Inc. from 2014 to 2019.
Prior to that, she worked as a Director of Regulatory Affairs at DexCom, Inc. from 2006 to 2008 and as a Manager of Clinical Trials at Cygnus, Inc. Additionally, she earned an undergraduate degree from St. Mary's College of California in 1998.
Former positions of Amy VandenBerg
| Companies | Position | End |
|---|---|---|
| DEXCOM, INC. | General Counsel | 2008-11-30 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
| VYOME HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Amy VandenBerg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Amy VandenBerg
